Ligand-targeted liposomal anticancer drugs

Author： Sapra P.   Allen T.M.  

Publisher： Elsevier

ISSN： 0163-7827

Source： Progress in Lipid Research, Vol.42, Iss.5, 2003-09, pp. : 439-462

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Anticancer Agents Targeted to Sirtuins

By Kozako Tomohiro   Suzuki Takayoshi   Yoshimitsu Makoto   Arima Naomichi   Honda Shin-ichiro   Soeda Shinji  

Molecules, Vol. 19, Iss. 12, 2014-12 ,pp. : 20295-20313

MDPI

Access to resources Recommend Favorite

Cyclophosphamide and related anticancer drugs

By Baumann F.   Preiss R.  

Journal of Chromatography. Biomedical Applications, Vol. 764, Iss. 1, 2001-11 ,pp. : 173-192

Elsevier

Access to resources Recommend Favorite

Augmented Anticancer Effects of Cantharidin with Liposomal Encapsulation: In Vitro and In Vivo Evaluation

By Zhang Xue   Lin Cong-Cong   Chan Wai-Kei-Nickie   Liu Kang-Lun   Yang Zhi-Jun   Zhang Hong-Qi  

Molecules, Vol. 22, Iss. 7, 2017-06 ,pp. : 1052-1052

MDPI

Access to resources Recommend Favorite

Histone Deacetylase Inhibitors as Anticancer Drugs

By Eckschlager Tomas   Plch Johana   Stiborova Marie   Hrabeta Jan  

International Journal of Molecular Sciences, Vol. 18, Iss. 7, 2017-07 ,pp. : 1414-1414

MDPI

Access to resources Recommend Favorite

Synthesis of Mannose‐Cholesterol Conjugates for Targeted Liposomal Drug Delivery

By  

ChemistrySelect, Vol. 1, Iss. 1, 2016-01 ,pp. : 31-35

John Wiley & Sons Inc

Access to resources Recommend Favorite